Challenges in inflammatory bowel disease [[electronic resource] /] / edited by Derek Jewell ... [et al.] |
Edizione | [2nd ed.] |
Pubbl/distr/stampa | Oxford, : Blackwell, 2006 |
Descrizione fisica | 1 online resource (414 p.) |
Disciplina | 616.344 |
Altri autori (Persone) | JewellD. P |
Soggetto topico |
Inflammatory bowel diseases
Internal medicine |
Soggetto genere / forma | Electronic books. |
ISBN |
1-280-74802-8
9786610748020 0-470-98494-5 0-470-75317-X 1-4051-7176-6 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Inflammatory Bowel Disease; Contents; List of Contributors and Editors; Preface; I Clues to aetiology and pathogenesis; 1 Global changes in incidence; 2 The role of genetics in infiammatory bowel disease; 3 Microbial sensing in the intestine by pattern recognition receptors; 4 The role of bacteria; 5 The appendix - how might it infiuence susceptibility to ulcerative colitis: the legend of Qebehsenuef; II Diagnosis and assessment; 6 What are the controversies in histopathological diagnosis?
7 The challenges of using capsule endoscopy in the diagnosis and management of infiammatory bowel disease8 Cross-sectional imaging of infiammatory bowel disease; III Management of ulcerative colitis; 9 Mesalazine for maintenance therapy in ulcerative colitis - how much, how long?; 10 Refractory distal colitis; 11 Pharmabiotics and infiammatory bowel disease - on the verge of evidence-based medicine; 12 Current controversies in the surgical management of ulcerative colitis; 13 What are the causes and treatment of ileoanal pouch dysfunction?; IV Management of Crohn's disease 14 Is mesalazine useful in Crohn's disease?15 Steroids or nutrition?; 16 Do antibiotics have a role in Crohn's disease?; 17 The optimal use of infiiximab in Crohn's disease; 18 Designer drugs: from bench to bedside; 19 Current controversies in the surgical management of Crohn's disease; 20 Perianal Crohn's disease; 21 What is dysplasia?; 22 Colonoscopic surveillance - if and when?; 23 Cancer: new colonoscopic techniques; 24 Molecular markers - a realistic hope?; 25 Adenomas versus dysplasia associated lesion or mass - recognition and management; V Special management problems 26 Growth impairment in children27 Osteopenia; 28 Pregnancy; 29 Can prognosis of ulcerative colitis be predicted?; Index |
Record Nr. | UNINA-9910143287103321 |
Oxford, : Blackwell, 2006 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Challenges in inflammatory bowel disease [[electronic resource] /] / edited by Derek Jewell ... [et al.] |
Edizione | [2nd ed.] |
Pubbl/distr/stampa | Oxford, : Blackwell, 2006 |
Descrizione fisica | 1 online resource (414 p.) |
Disciplina | 616.344 |
Altri autori (Persone) | JewellD. P |
Soggetto topico |
Inflammatory bowel diseases
Internal medicine |
ISBN |
1-280-74802-8
9786610748020 0-470-98494-5 0-470-75317-X 1-4051-7176-6 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Inflammatory Bowel Disease; Contents; List of Contributors and Editors; Preface; I Clues to aetiology and pathogenesis; 1 Global changes in incidence; 2 The role of genetics in infiammatory bowel disease; 3 Microbial sensing in the intestine by pattern recognition receptors; 4 The role of bacteria; 5 The appendix - how might it infiuence susceptibility to ulcerative colitis: the legend of Qebehsenuef; II Diagnosis and assessment; 6 What are the controversies in histopathological diagnosis?
7 The challenges of using capsule endoscopy in the diagnosis and management of infiammatory bowel disease8 Cross-sectional imaging of infiammatory bowel disease; III Management of ulcerative colitis; 9 Mesalazine for maintenance therapy in ulcerative colitis - how much, how long?; 10 Refractory distal colitis; 11 Pharmabiotics and infiammatory bowel disease - on the verge of evidence-based medicine; 12 Current controversies in the surgical management of ulcerative colitis; 13 What are the causes and treatment of ileoanal pouch dysfunction?; IV Management of Crohn's disease 14 Is mesalazine useful in Crohn's disease?15 Steroids or nutrition?; 16 Do antibiotics have a role in Crohn's disease?; 17 The optimal use of infiiximab in Crohn's disease; 18 Designer drugs: from bench to bedside; 19 Current controversies in the surgical management of Crohn's disease; 20 Perianal Crohn's disease; 21 What is dysplasia?; 22 Colonoscopic surveillance - if and when?; 23 Cancer: new colonoscopic techniques; 24 Molecular markers - a realistic hope?; 25 Adenomas versus dysplasia associated lesion or mass - recognition and management; V Special management problems 26 Growth impairment in children27 Osteopenia; 28 Pregnancy; 29 Can prognosis of ulcerative colitis be predicted?; Index |
Record Nr. | UNISA-996205523103316 |
Oxford, : Blackwell, 2006 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. di Salerno | ||
|
Challenges in inflammatory bowel disease [[electronic resource] /] / edited by Derek Jewell ... [et al.] |
Edizione | [2nd ed.] |
Pubbl/distr/stampa | Oxford, : Blackwell, 2006 |
Descrizione fisica | 1 online resource (414 p.) |
Disciplina | 616.344 |
Altri autori (Persone) | JewellD. P |
Soggetto topico |
Inflammatory bowel diseases
Internal medicine |
ISBN |
1-280-74802-8
9786610748020 0-470-98494-5 0-470-75317-X 1-4051-7176-6 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Inflammatory Bowel Disease; Contents; List of Contributors and Editors; Preface; I Clues to aetiology and pathogenesis; 1 Global changes in incidence; 2 The role of genetics in infiammatory bowel disease; 3 Microbial sensing in the intestine by pattern recognition receptors; 4 The role of bacteria; 5 The appendix - how might it infiuence susceptibility to ulcerative colitis: the legend of Qebehsenuef; II Diagnosis and assessment; 6 What are the controversies in histopathological diagnosis?
7 The challenges of using capsule endoscopy in the diagnosis and management of infiammatory bowel disease8 Cross-sectional imaging of infiammatory bowel disease; III Management of ulcerative colitis; 9 Mesalazine for maintenance therapy in ulcerative colitis - how much, how long?; 10 Refractory distal colitis; 11 Pharmabiotics and infiammatory bowel disease - on the verge of evidence-based medicine; 12 Current controversies in the surgical management of ulcerative colitis; 13 What are the causes and treatment of ileoanal pouch dysfunction?; IV Management of Crohn's disease 14 Is mesalazine useful in Crohn's disease?15 Steroids or nutrition?; 16 Do antibiotics have a role in Crohn's disease?; 17 The optimal use of infiiximab in Crohn's disease; 18 Designer drugs: from bench to bedside; 19 Current controversies in the surgical management of Crohn's disease; 20 Perianal Crohn's disease; 21 What is dysplasia?; 22 Colonoscopic surveillance - if and when?; 23 Cancer: new colonoscopic techniques; 24 Molecular markers - a realistic hope?; 25 Adenomas versus dysplasia associated lesion or mass - recognition and management; V Special management problems 26 Growth impairment in children27 Osteopenia; 28 Pregnancy; 29 Can prognosis of ulcerative colitis be predicted?; Index |
Record Nr. | UNINA-9910830822703321 |
Oxford, : Blackwell, 2006 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Challenges in inflammatory bowel disease / / edited by Derek Jewell ... [et al.] |
Edizione | [2nd ed.] |
Pubbl/distr/stampa | Oxford, : Blackwell, 2006 |
Descrizione fisica | 1 online resource (414 p.) |
Disciplina | 616.344 |
Altri autori (Persone) | JewellD. P |
Soggetto topico |
Inflammatory bowel diseases
Internal medicine |
ISBN |
1-280-74802-8
9786610748020 0-470-98494-5 0-470-75317-X 1-4051-7176-6 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Inflammatory Bowel Disease; Contents; List of Contributors and Editors; Preface; I Clues to aetiology and pathogenesis; 1 Global changes in incidence; 2 The role of genetics in infiammatory bowel disease; 3 Microbial sensing in the intestine by pattern recognition receptors; 4 The role of bacteria; 5 The appendix - how might it infiuence susceptibility to ulcerative colitis: the legend of Qebehsenuef; II Diagnosis and assessment; 6 What are the controversies in histopathological diagnosis?
7 The challenges of using capsule endoscopy in the diagnosis and management of infiammatory bowel disease8 Cross-sectional imaging of infiammatory bowel disease; III Management of ulcerative colitis; 9 Mesalazine for maintenance therapy in ulcerative colitis - how much, how long?; 10 Refractory distal colitis; 11 Pharmabiotics and infiammatory bowel disease - on the verge of evidence-based medicine; 12 Current controversies in the surgical management of ulcerative colitis; 13 What are the causes and treatment of ileoanal pouch dysfunction?; IV Management of Crohn's disease 14 Is mesalazine useful in Crohn's disease?15 Steroids or nutrition?; 16 Do antibiotics have a role in Crohn's disease?; 17 The optimal use of infiiximab in Crohn's disease; 18 Designer drugs: from bench to bedside; 19 Current controversies in the surgical management of Crohn's disease; 20 Perianal Crohn's disease; 21 What is dysplasia?; 22 Colonoscopic surveillance - if and when?; 23 Cancer: new colonoscopic techniques; 24 Molecular markers - a realistic hope?; 25 Adenomas versus dysplasia associated lesion or mass - recognition and management; V Special management problems 26 Growth impairment in children27 Osteopenia; 28 Pregnancy; 29 Can prognosis of ulcerative colitis be predicted?; Index |
Record Nr. | UNINA-9910877863503321 |
Oxford, : Blackwell, 2006 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|